|
161 |
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Enthalten in Nature medicine Bd. 24, 9.7.2018, Nr. 8, date:8.2018: 1192-1203
|
|
|
|
162 |
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients
Enthalten in Journal of neuro-oncology Bd. 149, 6.7.2020, Nr. 1, date:8.2020: 65-71
|
|
|
|
163 |
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
Enthalten in Acta neuropathologica Bd. 135, 24.1.2018, Nr. 4, date:4.2018: 601-615
|
|
|
|
164 |
Time-dependent parameter of perfusion imaging as independent predictor of clinical outcome in symptomatic carotid artery stenosis
Enthalten in BMC neurology Bd. 16, 19.4.2016, Nr. 1, date:12.2016: 1-9
|
|
|
|
165 |
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
Enthalten in BMC cancer Bd. 10, 9.11.2010, Nr. 1, date:12.2010: 1-8
|
|
|
|
166 |
Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma model
Enthalten in Scientific reports Bd. 14, 6.7.2024, Nr. 1, date:12.2024: 1-15
|
|
|
|
167 |
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Enthalten in Acta Neuropathologica Communications Bd. 7, 28.10.2019, Nr. 1, date:12.2019: 1-12
|
|
|
|
168 |
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
Enthalten in Nature Communications Bd. 16, 1.2.2025, Nr. 1, date:12.2025: 1-16
|
|
|
|
169 |
Vaccine Strategies in Gliomas
Enthalten in Current treatment options in neurology Bd. 20, 28.3.2018, Nr. 5, date:5.2018: 1-9
|
|
|
|
170 |
Vergleich von Behandlungspfaden beim akuten Schlaganfall – eine qualitative multizentrische Studie in drei zuweisenden Kliniken eines Schlaganfallnetzwerkes
Enthalten in Der Nervenarzt Bd. 94, 3.3.2023, Nr. 10, date:10.2023: 913-922
|
|
Administration
